What statements are required when submitting a Sequence Listing?

When submitting a Sequence Listing for a patent application, several statements are required according to MPEP 2427:

  • A statement that the “Sequence Listing” includes no new matter
  • A statement that indicates support for the amendment in the application, as filed
  • A statement that the content of the CRF is identical to the “Sequence Listing” part of the disclosure

These statements are crucial for ensuring compliance with 37 CFR 1.821-1.825. For example, 37 CFR 1.825(b)(5) requires “A statement that the ‘Sequence Listing’ added by amendment includes no new matter.” Failure to provide these statements can result in non-compliance and may require correction by the applicant.

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2427 - Form Paragraphs For Applications Subject To Wipo St.25, Patent Law, Patent Procedure
Tags: Biotechnology, Compliance, Required Statements, sequence listing